Involvement of cAMP response element-binding protein in the regulation of cell proliferation and the prolactin promoter of lactotrophs in primary culture

American Journal of Physiology - Endocrinology and Metabolism

Volumn 293, Issue 6, 2007, Pages

  Ishida, Maho ^a   Mitsui, Tetsuo ^a   Yamakawa, Koji ^a   Sugiyama, Nobuhiro ^a   Takahashi, Wakaba ^a   Shimura, Hiroki ^a   Endo, Toyoshi ^a   Kobayashi, Tetsurou ^a   Arita, Jun ^a  

^a UNIVERSITY OF YAMANASHI   (Japan)

Author keywords

Adenosine 3 ,5 cyclic monophosphate; Dopamine; Insulin like growth factor I

Indexed keywords

ADENYLATE CYCLASE; BROMOCRIPTINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; FORSKOLIN; LUCIFERASE; MESSENGER RNA; PROLACTIN; SOMATOMEDIN C; TETRACYCLINE;

ADENOVIRUS; ANIMAL CELL; ARTICLE; CELL CULTURE; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME ACTIVITY; GENE TARGETING; HYPOPHYSIS CELL; IMMUNOREACTIVITY; NONHUMAN; PRIORITY JOURNAL; PROLACTIN SECRETING CELL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; VIRUS RECOMBINANT;

ADENOVIRIDAE; ANIMALS; BROMOCRIPTINE; CELL PROLIFERATION; CELLS, CULTURED; CYCLIC AMP; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE AGONISTS; DOXYCYCLINE; FEMALE; FORSKOLIN; GENE EXPRESSION; INSULIN-LIKE GROWTH FACTOR I; LACTOTROPHS; PHOSPHORYLATION; PROLACTIN; PROMOTER REGIONS (GENETICS); RATS; RATS, WISTAR; RESPONSE ELEMENTS; TRANSFECTION;

EID: 37149052559     PISSN: 01931849     EISSN: 15221555     Source Type: Journal    
DOI: 10.1152/ajpendo.00028.2007     Document Type: Article

References (47)

1. Ben-Jonathan N, Hnasko R. Dopamine as a prolactin (PRL) inhibitor. Endocr Rev 22: 724-763, 2001.
2. Cass LA, Summers SA, Prendergast GV, Backer JM, Birnbaum MJ, Meinkoth JL. Protein kinase A-dependent and -independent signaling pathways contribute to cyclic AMP-stimulted proliferation. Mol Cell Biol 19: 5882-5891, 1999.
3. Castro MG, Goya RG, Sosa YE, Rowe J, Larregina A, Morelli A, Lowenstein PR. Expression of transgenes in normal and neoplastic anterior pituitary cells using recombinant adenoviruses: long term expression, cell cycle dependency, and effects on hormone secretion. Endocrinology 138: 2184-2194, 1997.
4. Chuang TT, Caccavelli L, Kordon C, Enjalbert A. Protein kinase C regulation of prolactin gene expression in lactotroph cells: involvement in dopamine inhibition. Endocrinology 132: 832-838, 1993.
5. Ciullo I, Diez-Roux G, Di Domenico M, Migliaccio A, Avvedimento EV. cAMP signaling selectively influences Ras effectors pathways. Oncogene 20: 1186-1192, 2001.
6. Coleman DT, Chen X, Sassaroli M, Bancroft C. Pituitary adenylate cyclase-activating polypeptide regulates prolactin promoter activity via a protein kinase-mediated pathway that is independent of the transcriptional pathway employed by thyrotropin-releasing hormone. Endocrinology 137: 1276-1285, 1996.
7. Deak M, Clifton AD, Lucocq LM, Alessi DR. Mitogen- and stress-activated protein kinase-1 (MSK1) is directly activated by MAPK and SAPK/p38, and may mediate activation of CREB. EMBO J 17: 4426-4441, 1998.
8. De Cesare D, Jacquot S, Hanauer A, Sassone-Corsi P. Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene. Proc Natl Acad Sci USA 95: 12202-12207, 1998.
9. de Rooij J, Zwartkruis FJ, Verheijen MH, Cool RH, Nijman SM, Wittinghofer A, Bos JL. Epac is a Rap1 guanine-nucleotide-exchange factor directly activated by cyclic AMP. Nature 396: 474-477, 1998.
10. Du K, Montminy M. CREB is a regulatory target for the protein kinase Akt/PKB. J Biol Chem 273: 32377-32379, 1998.
11. Elsholtz HP, Lew AM, Albert PR, Sundmark VC. Inhibitory control of prolactin and Pit-1 gene promoters by dopamine. J Biol Chem 266: 22919-22925, 1991.
12. Foulkes NS, Mellström B, Benusiglio E, Sassone-Corsi P. Developmental switch of CREM function during spermatogenesis: from antagonist to activator. Nature 355: 80-84, 1992.
13. Fujita T, Meguro T, Fukuyama R, Nakamuta H, Koida M. New signaling pathway for parathyroid hormone and cyclic AMP action on extracellular- regulated kinase and cell proliferation in bone cells. Checkpoint of modulatio by cyclic AMP. J Biol Chem 277: 22191-22200, 2002.
14. Gonzalez GA, Montminy MR. Cyclic AMP stimulates somatostatin gene transcription by phosphorylation of CREB at serine 133. Cell 59: 675-680, 1989.
15. Grady GC, Mason SM, Stephen J, Zuniga-Pflucker JC, Michie AM. Cyclic adenosine 5′-monophosphate response element binding protein plays a central role in mediating proliferation and differentiation downstream of the pre-TCR complex in developing thymocytes. J Immunol 173: 1802-1810, 2004.
16. Hurst H, Jones NC. Identification of factors that interact with the E1A-inducible adenovirus E3 promoter. Genes Dev 1: 1132-1146, 1987.
17. Iacovelli L, Capobianco L, Salvatore L, Sallese M, D'Ancona GM, De Blasi A. Thyrotropin activates mitogen-activated protein kinase pathway in FRTL-5 by a cAMP-dependent protein kinase A-independent mechanism. Mol Pharmacol 60: 924-933, 2001.
18. Kanasaki H, Fukunaga K, Takahashi K, Miyazaki K, Miyamoto E. Mitogen-activated protein kinase activation by stimulation with thyrotropin-releasing hormone in rat pituitary GH3 cells. Biol Reprod 61: 319-325, 1999.
19. Kawasaki H, Springett GM, Mochizuki N, Toki S, Nakaya M, Matsuda M, Housman DE, Graybiel AM. A family of cAMP-binding proteins that directly activate Rap1. Science 282: 2275-2279, 1998.
20. Kawashima K, Yamakawa K, Takahashi W, Takizawa S, Yin P, Sugiyama N, Kanba S, Arita J. The estrogen-occupied estrogen receptor functions as a negative regulator to inhibit cell proliferation induced by insulin/IGF-1: a cell context-specific antimitogenic action of estradiol on rat lactotrophs in culture. Endocrinology 143: 2750-2758, 2002.
21. Keech CA, Jackson SM, Siddiqui SK, Ocran KW, Gutierrez-Hartmann A. Cyclic adenosine 3′,-5′-monophosphate activation of the rat prolactin promoter is restricted to the pituitary-specific cell type. Mol Endocrinol 6: 2059-2070, 1992.
22. Laroche-Joubert N, Marsy S, Michelet S, Imbert-Teboul M, Doucet A. Protein kinase A-independent activation of ERK and H,K-ATPase by cAMP in native kidney cells: role of Epac 1. J Biol Chem 277: 18598-18604, 2002.
23. Lew AM, Yao H, Elsholtz HP. G(i) alpha 2- and G(o) alpha-mediated signaling in the Pit-1 dependent inhibition of the prolactin gene promoter. J Biol Chem 269: 12007-12013, 1994.
24. Liang J, Kim KE, Schoderbek WE, Maurer RA. Characterization of nontissue-specific, 3′,5′-cyclic adenosine monophosphate-responsive element in the proximal region of the rat prolactin gene. Mol Endocrinol 6: 885-892, 1992.
25. Liu JC, Baker RE, Sun C, Sundmark VC, Elsholtz HP. Activation of Go-coupled dopamine D2 receptors inhibits ERK1/ERK2 in pituitary cells. J Biol Chem 277: 35819-35825, 2002.
26. Matthews RP, Guthrie CR, Wailes LM, Zhao X, Means AR, McKnight GS. Calcium-calmodulin-dependent kinase types II and IV differentially regulate CREB-dependent gene expression. Mol Cell Biol 14: 6107-6116, 1994.
27. Maurer RA. Transcriptional regulation of the prolactin gene by ergocryptine and cyclic AMP. Nature 294: 94-97, 1981.
28. Maurer RA. Adenosine 3′,5′-monophosphate derivatives increase prolactin synthesis and prolactin messenger ribonucleic acid levels in ergocryptine-treated pituitary cells. Endocrinology 110: 1957-1963, 1982.
29. Mayr B, Montminy M. Transcriptional regulation by the phosphorylation-dependent factor CREB. Nat Rev Mol Cell Biol 2: 599-609, 2001.
30. Neill JD, Musgrove LC, Duck LW, Sellers J. High efficiency method for gene transfer in normal pituitary gonadotropes: adenoviral-mediated expression of G protein-coupled receptor kinase 2 suppresses luteinizining hormone secretion. Endocrinology 140: 2562-2569, 1999.
31. Pugazhenthi S, Boras T, O'Connor D, Meintzer MK, Heidenreich KA, Reusch JE. Insulin-like growth factor I-mediated activation of the transcription factor cAMP response element-binding protein in PC12 cells. J Biol Chem 274: 2829-2837, 1999.
32. Richards JS. New signaling pathways for hormones and cyclic adenosine 3′,5′-monophosphate action in endocrine cells. Mol Endocrinol 15: 209-218, 2001.
33. Schmitt JM, Stork PJ. Cyclic AMP-mediated inhibition of cell growth requires the small G protein Rap1. Mol Cell Biol 21: 3671-3683, 2001.
34. Shankar DB, Cheng JC, Kinjo K, Federman N, Moore T, Gill A, Rao NP, Landaw EM, Sakamoto KM. The role of CREB as a proto-oncogene in hematopoiesis and in acute myeloid leukemia. Cancer Cell 7: 351-362, 2005.
35. Shaywitz AJ, Greenberg ME. CREB: a stimulus-induced transcription factor activated by a diverse array of extracellular signals. Annu Rev Biochem 68: 821-861, 1999.
36. Stork PJ, Schmitt JM. Crosstalk between cAMP and MAP kinase signaling in the regulation of cell proliferation. Trends Cell Biol 12: 258-266, 2002.
37. Struthers RS, Vale WW, Arias C, Sawchenko PE, Montminy MR. Somatotroph hypoplasia and dwarfism in transgenic mice expressing a non-phosphorylatable CREB mutant. Nature 350: 622-624, 1991.
38. Suzuki S, Yamamoto I, Arita J. Mitogen-activated protein kinase-dependent stimulation of proliferation of rat lactotrophs in culture by 3′,5′-cyclic adenosine monophosphate. Endocrinology 140: 2850-2858, 1999.
39. Swennen L, Denef C. Physiological concentrations of dopamine decrease adenosine 3′,5′-monophosphate levels in cultured rat anterior pituitary cells and enriched populations of lactotrophs: evidence for a causal relationship to inhibition of prolactin release. Endocrinology 111: 398-405, 1982.
40. Tan Y, Rouse J, Zhang A, Cariati S, Cohen P, Comb MJ. FGF and stress regulate CREB and ATF-1 via a pathway involving p38 MAP kinase and MAPKAP kinase-2. EMBO J 17: 4629-4642, 1996.
41. Tokunou T, Ichiki T, Takeda K, Funakoshi Y, Iino N, Takeshita A. cAMP response element-binding protein mediates thrombin-induced proliferation of vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 21: 1764-1769, 2001.
42. Vossler MR, Yao H, York RD, Pan M, Rim CS, Stork PJ. cAMP activates MAP kinase and Elk-1 through a B-Raf- and Rap1-dependent pathway. Cell 89: 73-82, 1997.
43. Woloshin PI, Walton KM, Rehfuss RP, Goodman RH, Cone RD. 3′,5′-cyclic adenosine monophosphate-regulated enhancer binding (CREB) activity is required for normal growth and differentiated phenotype in the FRTL5 thyroid follicular cell line. Mol Endocrinol 6: 1725-1733, 1992.
44. Xing J, Ginty DD, Greenberg ME. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273: 959-963, 1996.
45. Yamakawa K, Arita J. Cross-talk between the estrogen receptor-, protein kinase A-, and mitogen-activated protein kinase-mediated signaling pathways in the regulation of lactotroph proliferation in primary culture. J Steroid Biochem Mol Biol 88: 123-130, 2004.
46. Yamamoto KK, Gonzalez GA, Biggs WH 3rd, Montminy MR. Phosphorylation-induced binding and transcriptional efficacy of nuclear factor CREB. Nature 334: 494-498, 1988.
47. Zhang X, Odom DT, Koo S, Conkright MD, Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen E, Kadam S, Ecker JR, Emerson B, Hogenesch JB, Unterman T, Young RA, Montminy M. Genomo-wide analysis of cAMP-response element binding protein occupancy, phosphorylation, and target gene activation in human tissues. Proc Natl Acad Sci USA 102: 4459-4464, 2005.